MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 18.04.2026
QIAGEN N.V. DSO 2011-2026 | QGEN
DSO Jährlich QIAGEN N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 30.8 | 74.7 | 88.1 | 82.7 | 78.2 | 89.5 | 92.9 | 86.5 | 93.7 | 89.4 | 77.9 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 93.7 | 30.8 | 80.4 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
94.7 | $ 1.67 | - | $ 2.22 M |  USA |
 |
Castle Biosciences
CSTL
|
49.2 | $ 24.46 | - | $ 679 M | USA |
 |
Agilent Technologies
A
|
63.8 | $ 115.55 | - | $ 35.1 B | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
61.3 | $ 127.88 | - | $ 20.3 B | USA |
 |
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
Lantheus Holdings
LNTH
|
80.5 | $ 84.33 | - | $ 5.69 B | USA |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 21.23 | - | $ 1.13 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M |  Britain |
 |
Senseonics Holdings
SENS
|
10.3 | $ 7.05 | - | $ 294 M | USA |
 |
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 16.31 | - | $ 493 M | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 469.71 | - | $ 177 B | USA |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M |  China |
 |
Trinity Biotech plc
TRIB
|
87.2 | $ 0.65 | -1.84 % | $ 61.9 M |  Irlanda |
 |
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
Twist Bioscience Corporation
TWST
|
44.5 | $ 60.94 | - | $ 3.64 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 169.8 | - | $ 8.42 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
 |
Guardant Health
GH
|
46.1 | $ 88.91 | - | $ 11.1 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
66.9 | $ 1.98 | -2.37 % | $ 8.76 M | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 410.54 | - | $ 11.8 B | USA |
 |
Exagen
XGN
|
51.2 | $ 2.7 | 0.75 % | $ 58.2 M | USA |
 |
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K |  Israel |
 |
Neogen Corporation
NEOG
|
66.6 | $ 9.54 | - | $ 2.07 B | USA |
 |
Biomerica
BMRA
|
57.7 | $ 2.14 | - | $ 4.92 M | USA |
 |
National Research Corporation
NRC
|
29.4 | $ 17.23 | - | $ 386 M | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 102.17 | - | $ 8.43 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 263.8 | - | $ 21.9 B | USA |
 |
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
77.7 | $ 8.29 | - | $ 1.06 B | USA |
 |
Myriad Genetics
MYGN
|
52.3 | $ 4.78 | - | $ 443 M | USA |
 |
Natera
NTRA
|
81.5 | $ 203.75 | - | $ 20.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 196.27 | - | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | USA |